Tranquillizing effects of propranolol demonstrated in rats.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists; D000818:Animals; D001007:Anxiety / Q000187:drug effects; D001285:Atropine / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects*; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003213:Conditioning, Psychological; D003864:Depression, Chemical; D004597:Electroshock; D006220:Haloperidol / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006801:Humans; D007535:Isomerases; D008297:Male; D010634:Phenobarbital / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013238:Stereotaxic Techniques; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D006584:Hexamethonium Compounds; D010643:Phenoxybenzamine; D002707:Chlordiazepoxide; D001285:Atropine; D011433:Propranolol; D007535:Isomerases; D006220:Haloperidol; D002746:Chlorpromazine; D010634:Phenobarbital